Leadership Overview
Broad Institute has 8 executives leading key functions including financial oversight, information technology, operational management, fiscal planning, executive coordination, human resources, communications, and strategic advisory.
Committed to advancing human health through genomic research, Broad Institute accelerates the discovery of new therapies by fostering collaborative scientific innovation and rigorous data-driven inquiry.
Committed to advancing human health through genomic research, Broad Institute accelerates the discovery of new therapies by fostering collaborative scientific innovation and rigorous data-driven inquiry.
Leadership Roles at Broad Institute
Emme Handy - Chief Financial Officer
Emme Handy, the Chief Financial Officer at Broad Institute, directs all fiscal strategy and resource allocation to support large-scale genomic research initiatives. Managing the complex budgetary requirements of a premier research organization, the Chief Financial Officer ensures financial sustainability across diverse scientific programs. Handy oversees long-term capital planning and grant management, maintaining rigorous compliance standards while optimizing funding streams for high-impact biological studies. By aligning fiscal policy with the broader mission of discovering new treatments for human diseases, the Chief Financial Officer provides the necessary economic foundation for laboratory operations. Emme Handy maintains close collaboration with the Board to ensure transparency and accountability in all financial reporting. Through meticulous oversight of institutional assets, the Chief Financial Officer secures the resources required for sustained scientific breakthroughs, ultimately driving the financial health of the organization within the competitive global research landscape.
Wanda Cordova - Deputy Chief Financial Officer
Wanda Cordova, the Deputy Chief Financial Officer at Broad Institute, executes detailed financial analysis and internal auditing to support the organization's fiscal stability. Assisting in the management of complex grant portfolios, the Deputy Chief Financial Officer monitors expenditure patterns to ensure alignment with institutional research goals. Cordova oversees the daily accounting operations and financial reporting processes, providing the data necessary for informed decision-making by senior leadership. By refining internal controls and financial procedures, the Deputy Chief Financial Officer strengthens the economic framework supporting genomic research. Wanda Cordova collaborates with departmental heads to manage budgets effectively, ensuring that resources reach critical scientific projects without delay. This leadership role involves maintaining rigorous financial oversight to support the long-term viability of the institute's research mission. Through precise fiscal management and analytical rigor, the Deputy Chief Financial Officer contributes to the overall financial health and operational success of the organization.
Dan Shore - Chief Operating Officer
Dan Shore, the Chief Operating Officer at Broad Institute, manages the daily operational functions that sustain a world-class research environment. Overseeing facility management, laboratory logistics, and administrative workflows, the Chief Operating Officer ensures that scientific teams possess the physical and organizational support needed for discovery. Shore coordinates cross-departmental efforts to streamline project execution, reducing bottlenecks in the research pipeline. By optimizing internal processes, the Chief Operating Officer enhances the efficiency of the entire organization, allowing scientists to focus exclusively on finding new therapies for human diseases. Dan Shore maintains rigorous standards for operational excellence, ensuring that all laboratory activities adhere to safety and quality protocols. This leadership role involves managing the physical infrastructure and administrative systems that underpin the institute's mission. Through strategic oversight of daily operations, the Chief Operating Officer facilitates the seamless integration of diverse research programs, ultimately supporting the organization's goal of transforming human health.
Jennifer Hopkins - Chief Information Officer
Jennifer Hopkins, the Chief Information Officer at Broad Institute, architects the digital infrastructure necessary for processing massive genomic datasets. Overseeing the integration of advanced computational tools, the Chief Information Officer enables researchers to analyze complex biological information with unprecedented speed and accuracy. Hopkins manages the cybersecurity framework and data storage solutions that protect sensitive research findings while facilitating secure collaboration across international scientific networks. By modernizing the technological stack, the Chief Information Officer supports the rapid translation of data into actionable therapeutic insights. Jennifer Hopkins drives the digital transformation strategy, ensuring that computational resources remain at the cutting edge of modern medicine. This leadership role involves coordinating with scientific teams to deploy scalable software platforms that enhance research productivity. Through the implementation of robust information systems, the Chief Information Officer maintains the technological integrity required for the organization to lead in the field of human disease research.
Emily Botelho - Chief of Staff & To David R Liu Senior Advisor
Emily Botelho, the Chief of Staff & To David R Liu Senior Advisor at Broad Institute, coordinates strategic initiatives and facilitates communication between executive leadership and scientific teams. Managing the flow of information and priorities, the Chief of Staff & To David R Liu Senior Advisor ensures that the director's vision translates into actionable programs across the institute. Botelho oversees the planning of high-level meetings and institutional projects, maintaining alignment with the core mission of researching human diseases. By streamlining executive workflows, the Chief of Staff & To David R Liu Senior Advisor enhances the productivity of the leadership team and fosters collaboration across departments. Emily Botelho manages complex stakeholder relationships, ensuring that strategic goals remain the primary focus of all organizational activities. This leadership role involves providing critical support for the director's initiatives, ultimately driving the success of the institute's research agenda through effective coordination and strategic planning.
Sarah Cox - Chief People Officer
Sarah Cox, the Chief People Officer at Broad Institute, directs human capital strategy to attract and retain top-tier scientific and administrative talent. Overseeing recruitment, professional development, and organizational culture, the Chief People Officer ensures that the workforce remains highly motivated and aligned with the mission of discovering new therapies. Cox manages talent acquisition programs that bring diverse expertise into the research environment, fostering an atmosphere of innovation and collaboration. By implementing comprehensive training and wellness initiatives, the Chief People Officer supports the growth and well-being of all employees. Sarah Cox drives the development of inclusive policies that promote equity and excellence across the organization. This leadership role involves managing the human resources infrastructure that enables the institute to thrive in the competitive research sector. Through strategic talent management, the Chief People Officer ensures that the organization possesses the human capital necessary to lead in the field of genomics.
Lee McGuire - Chief Communications Officer (Cco)
Lee McGuire, the Chief Communications Officer (Cco) at Broad Institute, manages the public image and institutional messaging of the organization. Overseeing media relations, digital outreach, and internal communications, the Chief Communications Officer (Cco) ensures that the impact of genomic research reaches a global audience. McGuire develops strategies to articulate the value of the institute's work to stakeholders, donors, and the scientific community. By crafting clear and compelling narratives, the Chief Communications Officer (Cco) enhances the reputation of the organization as a leader in the search for new human disease therapies. Lee McGuire coordinates communication efforts to highlight major research breakthroughs and institutional milestones. This leadership role involves managing the brand identity and ensuring consistent messaging across all platforms. Through effective communication strategies, the Chief Communications Officer (Cco) builds public trust and supports the organization's mission by fostering a deeper understanding of the importance of genomic science.
Ellen Law - Senior Advisor To the Director
Ellen Law, the Senior Advisor To the Director at Broad Institute, provides high-level strategic guidance on research priorities and institutional growth. Analyzing emerging trends in genomics and biotechnology, the Senior Advisor To the Director assists in shaping the long-term vision for the organization's scientific programs. Law evaluates potential partnerships and research opportunities, ensuring that the institute remains at the forefront of medical innovation. By providing expert counsel to the director, the Senior Advisor To the Director helps navigate complex scientific and administrative challenges. Ellen Law facilitates the development of new initiatives that align with the core mission of finding therapies for human diseases. This leadership role involves synthesizing complex information to support executive decision-making and institutional strategy. Through rigorous analysis and strategic foresight, the Senior Advisor To the Director contributes to the continued success and scientific leadership of the organization in the global research community.
Explore Leadership Teams in Business Services
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership FB
GS
Founded in 1969, Bionetics Corporation is a company that offers environmental monitoring, readiness monitoring, and instrument calibration services. They are based in Yorktown, Virginia.
Company Leadership KV
TM
DT
HR
Beam Therapeutics is a biotechnology company developing precision genetic medicines using base editing. The company advances research and clinical programs aimed at providing durable treatments for serious diseases, supported by scientific leadership and drug development capabilities. Beam focuses on translating genome editing science into potential lifelong therapies for patients.
Company Leadership JE
CB
GC
Embrapa (Brazilian Agricultural Research Corporation) is a Brazilian public research institution headquartered in Brasilia, Brazil. Founded in 1973 and linked to the Ministry of Agriculture, Embrapa conducts agricultural research and development to improve productivity, sustainability, and competitiveness of Brazilian agriculture. The organization operates a network of research centers across Brazil.
Company Leadership RC
SM
Frequently Asked Questions Regarding Broad Institute Top Executives and Leadership Team
